These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3053564)

  • 1. Early studies on in-vitro and experimental activity of spiramycin: a review.
    Chabbert YA
    J Antimicrob Chemother; 1988 Jul; 22 Suppl B():1-11. PubMed ID: 3053564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro activity of roxithromycin against respiratory and skin pathogens.
    Pechére JC; Auckenthaler R
    J Antimicrob Chemother; 1987 Nov; 20 Suppl B():1-5. PubMed ID: 3501424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The comparative in vitro activity of spiramycin and erythromycin against Norwegian bacterial isolates.
    Dibb WL; Ragnhildstveit E
    NIPH Ann; 1986 Dec; 9(2):61-3. PubMed ID: 3101004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative in vitro bacteriostatic and bactericidal effect of 5 macrolides: roxithromycin, erythromycin, oleandomycin, josamycin and spiramycin against 284 hospital bacterial strains].
    Le Noc P; Croize J; Bryskier A; Le Noc D; Robert J
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):553-9. PubMed ID: 2797879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sub-inhibitory and post-antibiotic effects of spiramycin and erythromycin on Staphylococcus aureus.
    Webster C; Ghazanfar K; Slack R
    J Antimicrob Chemother; 1988 Jul; 22 Suppl B():33-9. PubMed ID: 3182445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro antibacterial activity of a new macrolide: miokamycin. Comparison with erythromycin and josamycin].
    Soussy CJ; Leclercq R; Duval J
    Pathol Biol (Paris); 1988 May; 36(5):370-6. PubMed ID: 3043331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spiramycin paradox.
    Smith CR
    J Antimicrob Chemother; 1988 Jul; 22 Suppl B():141-4. PubMed ID: 3053567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in-vitro activity of roxithromycin, a new macrolide antibiotic, in comparison with that of erythromycin.
    King A; Phillips I
    Drugs Exp Clin Res; 1987; 13(9):563-6. PubMed ID: 3428135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of rodogyl against putative periodontopathic bacteria.
    Quee TC; Roussou T; Chan EC
    Antimicrob Agents Chemother; 1983 Sep; 24(3):445-7. PubMed ID: 6639002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of clindamycin, erythromycin and spiramycin against Staphylococcus aureus in the rat croton oil pouch model.
    Davey PG; Jacobus NV; Tally FP
    J Antimicrob Chemother; 1987 Nov; 20(5):705-12. PubMed ID: 3429372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of spiramycin against chlamydia, in vitro and in vivo.
    Orfila J; Haider F; Thomas D
    J Antimicrob Chemother; 1988 Jul; 22 Suppl B():73-6. PubMed ID: 3182449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antipneumococcal activity of erythromycin and spiramycin in 2 experimental models in mice].
    Rolin O; Bouanchaud DH
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):742-5. PubMed ID: 3309807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro antibacterial activity of a new macrolide, miokamycin. Results of a multicenter study].
    Soussy CJ; Thabaut A; Bismuth R; Morel C; Berthelot G; Chanal M; Derlot E
    Pathol Biol (Paris); 1989 May; 37(5):358-63. PubMed ID: 2674868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Susceptibility of potential periodontopathic bacteria to metronidazole, spiramycin and their combination].
    Mouton C; Dextraze L; Mayrand D
    J Biol Buccale; 1984 Mar; 12(1):17-26. PubMed ID: 6584423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metronidazole and spiramycin therapy of mixed Bacteroides spp. and Neisseria gonorrhoeae infection in mice.
    Brook I
    Chemotherapy; 1989; 35(2):105-12. PubMed ID: 2503299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metronidazole and spiramycin in abscesses caused by Bacteroides spp. and Staphylococcus aureus in mice.
    Brook I
    J Antimicrob Chemother; 1987 Nov; 20(5):713-8. PubMed ID: 3429373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spiramycin, a macrolide antibiotic.
    Abou-Zeid AZ; Khalil A el-G ; Rabei M
    Zentralbl Bakteriol Naturwiss; 1980; 135(5):443-53. PubMed ID: 6779436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of spiramycin on adhesiveness and phagocytosis of gram-positive cocci.
    Desnottes JF; Diallo N; Moret G
    J Antimicrob Chemother; 1988 Jul; 22 Suppl B():25-32. PubMed ID: 3182444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of bactericidal effect of the spiramycin and minocycline on Mycoplasma pneumoniae].
    Renaudin H; de Barbeyrac B; Bebear C
    Pathol Biol (Paris); 1987 May; 35(5):595-8. PubMed ID: 3112711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the pharmacokinetics and tissue penetration of spiramycin and erythromycin.
    Kavi J; Webberley JM; Andrews JM; Wise R
    J Antimicrob Chemother; 1988 Jul; 22 Suppl B():105-10. PubMed ID: 3182434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.